Breaking News

Medicine

India to witness over 6% employment growth across key industries in April-September

India is set to see significant employment growth in the first half of the current fiscal year (FY25) across key industries, led by healthcare, pharma, automotive, manufacturing, engineering and infrastructure sectors, a report showed on Thursday. The country’s employment market is likely to see an expansion of more than six per cent in the first…

Read More

Balaxi Pharmaceuticals announces global expansion

Balaxi Pharmaceuticals Limited has announced global expansion. In an exchange filing, the company shared details about strategic hospital partnerships in Angola and securing tender business in Latin America.  The company said that it has tied up with approximately 50 hospitals across Angola. Also, it is working towards having tie-ups with more than 150 hospitals across the…

Read More

USFDA pulls up Natco Pharma for manufacturing lapses at Telangana plant

Natco Pharma failed to maintain cleanliness, sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US health regulator. In the warning letter to the company, US Food and Drug Administration said its investigators observed various violations at the finished pharmaceuticals plant located at Kothur Village in Telangana. The USFDA inspected…

Read More

Cipla to acquire Ivia Beaute’s cosmetics, personal care distribution and marketing biz for Rs 130 crore

Pharma major Cipla Ltd will acquire the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd, including the latter’s brands Astaberry, Ikin and Bhimsaini, on a worldwide basis for Rs 130 crore, according to a regulatory filing by the company. Cipla Health Ltd (CHL), a wholly owned subsidiary and consumer healthcare…

Read More

Cipla Q4 net profit jumps over 2-fold to Rs 357.68 cr; to raise up to Rs 6,000 cr

Drug major Cipla Wednesday reported over two-fold jump in consolidated net profit to Rs 357.68 crore for the fourth quarter ended March 31, mainly on account of robust sales across markets. The company has also decided to raise funds of up to Rs 6,000 crore. It had posted a net profit of Rs 153.25 crore…

Read More

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood. Citing IQVIA sales data, Glenmark said Vytorin tablets’ market achieved annual sales of approximately USD 92.4 million for the 12-month period ended April 2019. Image source:…

Read More

Aarti Drugs has a CapEx Plan of Rs 600 crore for Greenfield Projects: Adhish Patil, CFO

Adhish Patil, CFO, Aarti Drugs Ltd, talks about Q3FY21 numbers, PLI Scheme, CapEx and budget expectations during a candid chat with Swati Khandelwal, Zee Business in the run-up to the Union Budget 2021-22. Excerpts: Q: Congratulations! you have posted strong numbers for the third quarter FY21. Going forward, do you think that these numbers are sustainable?…

Read More

Exclusive: In chat with Anil Singhvi, IOL Chemicals’ Joint MD Sandeep Garg discusses Q3 results, business outlook

In today’s episode of News Par Views, Zee Business Managing Editor Anil Singhvi spoke to Sandeep Garg, Joint Managing Director (Jt MD) of IOL Chemicals. The company was started in 1986 and is a manufacturer of popular pain killer ibuprofen. It started a plant for ibuprofen in 2000 and later made a multipurpose plant. (#NewsParViews)  Garg said that the…

Read More

Dr Reddy’s Lab inks licensing pact with US-based Slayback Pharma

The company has inked a licensing pact with the NewJersey-based drug firm to acquire rights in Brimonidine Tartrate Ophthalmic Solution 0.025 percent, the Hyderabad-based firm said in a statement. As per industry estimates, the value of the total addressable market for this product in the US is around USD 130 million for the 52 weeks…

Read More

Dollar Index jumps to 5-week high: Analysts decode its impact on IT, Pharma and Apparel sector – What should investors know

For some sectors, it’s good news, and for some it’s bad, the dollar index has jumped to a five-week high on Friday to 109 level, which is the highest since July 15 in the anticipation of US Fed Reserve another rate hike and on recessionary concerns.   Export services sector such as Information and Technology as…

Read More